Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Balaxi Pharmaceuticals had annual revenue of 2.89B INR with 19.71% growth. Balaxi Pharmaceuticals had revenue of 745.73M in the quarter ending March 31, 2025, with 24.63% growth.

• Revenue: 2.89B
• Revenue Growth: +19.71%
• P/S Ratio: 0.90
• Revenue / Employee: 4.88M
• Employees: 600
• Market Cap: 2.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.89B	475.50M	19.71%
Mar 31, 2024	2.41B	-951.38M	-28.28%
Mar 31, 2023	3.36B	570.45M	20.42%
Mar 31, 2022	2.79B	480.55M	20.77%
Mar 31, 2021	2.31B	1.86B	406.95%